Author: John Pinching

Data shows survival benefit in BRAFV600E‑mutant metastatic colorectal cancer

Findings strengthen rationale for EMERALD trial of engineered macrophage therapy RTX001

Phase 1 study to assess safety and early efficacy of KMA‑targeting car‑t in multiple myeloma

Phase 2 bridge data show consistent outcomes in patients with impaired kidney function

Trial shows first head‑to‑head superiority in joint endpoints for an approved PsA biologic